Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Bionano Genomics Inc. logo

Bionano Genomics Inc.

Sector: Healthcare   

Industry: Diagnostics & Research

Optionable: Yes  Market Cap: 57 M  90-day average vol: 1,256,838

Previous close: 0.844  Open: 0.8324  Bid: 0.8175  Ask: 0.8265
52 week range    
Last updated: Monday 17th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord



StockDividendMarket Cap (B)PEPrice ($)

BNGO Income Statement

Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-100000.0-1 M-6 M
Basic EPS total-1.74-0.39-0.26-0.46
Basic weighted shares outstanding7 M15 M104 M277 M289 M
Cost of sales-9 M-7 M-6 M-14 M-22 M
Depreciation-1 M-1 M-1 M-2 M-4 M
DepreciationAndAmortization-1 M-1 M-1 M-2 M-4 M
Diluted EPS total-2.61-1.99-0.39-0.26-0.46
Diluted weighted shares outstanding7 M15 M105 M277 M289 M
GeneralAndAdministrativeExpense-556321.0-171796.0-887000.0-2 M-3 M
Gross operating profit3 M3 M3 M4 M6 M
Income before tax-18 M-30 M-41 M-78 M-131 M
Income restructuring and M&A92 M143 M
Income taxes15511.021048.029000.0-6 M2 M
Interest income2 M2 M
InterestExpenseNonOperating1 M2 M3 M927000.0298000.0
MiscOtherSpecialCharges3 M-2 M-7000.0-2 M-223000.0
Net income from total operations-18 M-30 M-41 M-72 M-133 M
NetIncomeCommonStockholders-18 M-30 M-41 M-72 M-133 M
NetIncomeContinuousOperations-18 M-30 M-41 M-72 M-133 M
NetNonOperatingInterestIncomeExpense-1 M-2 M-3 M1 M1 M
Operating income-20 M-26 M-39 M-77 M-132 M
Operating income before depreciation (EBITDA)-16 M-26 M-37 M-74 M-121 M
OperatingExpense24 M29 M41 M81 M138 M
Other income net-3 M2 M7000.02 M223000.0
OtherGandA-556321.0-171796.0-887000.0-2 M-3 M
OtherOperatingExpenses-370573.0-554867.0-2 M-1 M-2 M
Research & development expense9 M9 M10 M22 M49 M
ResearchExpense9 M9 M10 M22 M49 M
RestructringAndMnAIncome92 M143 M
Revenue per share-225052.0-225052.0-100000.0-1 M-6 M
SalariesAndWages-1 M-1 M-2 M-10 M-22 M
Selling Gen & administrative expense14 M20 M31 M58 M89 M
SellingAndMarketingExpense14 M20 M31 M58 M89 M
SellingExpense14 M20 M31 M58 M89 M
Special income/charges-92 M-143 M
Total Income available for interest expense (EBIT)-17 M-28 M-39 M-77 M-130 M
Total common shares outstanding10 M38 M279 M290 M306 M
Total net income-18 M-30 M-41 M-72 M-133 M
Total ordinary shares67 M67 M67 M67 M67 M
Total revenues12 M10 M9 M18 M28 M
TotalExpenses15 M22 M36 M67 M116 M
TotalRevenue12 M10 M9 M18 M28 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University